Abstract Analysis of genes involved in yeast cell wall //-glucan assembly has led to the isolation of EXG1, PBS2 and PTC1. EXGt and PBS2 were isolated as genes that, when expressed from multicopy plasmids, led to a dominant killer toxin-resistant phenotype. The PTC1 gene was cloned by functional complementation of the calcofluor white-hypersensitive mutant cwh47-1. PTC1/CWH47 is the structural gene for a type 2C serine/threonine phosphatase, EXG1 codes for an exo-/~-glucanase, and PBS2 encodes a MAP kinase kinase in the Pbs2p-Hoglp signal transduction pathway. Overexpression of EXG1 on a 2# plasmid led to reduction in a cell wall//1,6-glucan and caused killer resistance in wild type cells; while the exglA mutant displayed modest increases in killer sensitivity and //1,6-glucan levels. Disruption of PTC1/CWH47 and overexpression of PBS2 gave rise to similar/Lglucan related phenotypes, with higher levels of EXG1 transcription, increased exo-//-glucanase activity, reduced //1,6-glucan levels, and resistance to killer toxin. Genetic analysis revealed that loss of function of the PBS2 gene was epistatic to PTC1/CWH47 disruption, indicating a functional role for the Ptclp/Cwh47p phosphatase in the Pbs2p-Hoglp signal transduction pathway. These results suggest that Ptclp/Cwh47p and Pbs2p play opposing regulatory roles in cell wall glucan assembly, and that this is effected in part by modulating Exglp activity.
Introduction
//-Glucans, homopolymers of glucose, are the main structural components responsible for the shape and rigidity of the yeast cell wall (Fleet and Phaff 1981) . Based upon their chemical linkage characteristics,//-glucans can be subdivided into two distinct polymer types://1,3-glucan and//1,6-glucan. The//1,3-glucan is the more abundant component, containing approximately 1500 glucose residues per molecule. It consists of a predominantly 1,3-1inked linear molecule with approximately 3 % 1,6-linkages at branchpoints (Manners et al. 1973a ). The/~l,6-glucan is a smaller and highly branched molecule comprised largely of 1,6-1inked residues with a small proportion of 1,3-1inked residues. The average size of//1,6-glucan is approximately 140 200 residues per molecule (Boone et al. 1990; Manners et al. 1973b) .
Studies on K1 killer toxin-resistant mutants have led to the identification and molecular characterization of several KRE (killer resistant) genes required for the synthesis of//1,6-glucan. KRE5 encodes a potential endoplasmic reticulum (ER) protein essential for//1,6-glucan synthesis (Meaden et al. 1990 ). KRE6 and SKN1 are a pair of functional homologs coding for type II integral membrane proteins located in the Golgi apparatus (Roemer and Bussey 1991; Roemer et al. 1993 Roemer et al. , 1994 . KREll codes for a 63 KDa cytoplasmic protein . KRE1 encodes a serine/threonine-rich protein, which is probably anchored to the plasma membrane by its hydrophobic C-terminal tail (Boone et al. 1990) . KRE9 is the structural gene for a small, serine/threonine-rich secretory O-glycoprotein . Null mutations in these genes disrupt the normal synthesis of //1,6-glucan in various ways leading to reduced levels of the polymer and a killer-resistant phenotype. Based on the molecular and genetic analyses of these kre null mutants, it has been suggested that //1,6-glucan is synthesized by a stepwise sequential process in the secretory pathway Roemer et al. 1993) . A few genes implicated in fl,3-glucan synthesis have also been described. Recently, DiDomenico's group cloned the KNR4 gene by functional complementation of a K9 killer toxin resistant mutant (Hong et al. 1994) . The KNR4 gene encodes a highly charged, acidic protein. Disruption of the gene led to reductions in both fll,3-glucan synthase activity and cell wall fll,3-glucan content, indicating that the KNR4 gene might play a functional role in fll,3-glucan synthesis. The Pkclp-Mpklp/Slt2p MAP kinase cascade has also been suggested to be involved in cell wall glucan assembly, because mutants in this kinase cascade display cell lysis phenotypes (Errede and Levin 1993; Torres et al. 1991) , and because mutations in the PKC1 gene result in reductions in both fll,3-glucan and fl,6-glucan levels in the cell wall (Roemer et al. 1994; Shimizu et al. 1994) .
Saccharomyces cerevisiae produces several endo-and exo-fl-glucanases during vegetative growth, and it has been hypothesized that these enzymes are involved in various morphogenetic events, such as cell expansion, budding, conjugation and sporulation, that require controlled and localized hydrolysis of cell wall flglucans (Abd-el-al and Phaff 1968; Farkas et al. 1973; Fleet and Phaff 1981; Hien and Fleet 1983; Sanchez et al. 1982) . To date, four glucanase genes, EXG1, EXG2, BGL2 and SPR1/SSG1, have been cloned in S. cerevisiae. EXG1 codes for an abundant, apparently non-specific, exo-fl-glucanase that is active in vitro on both/31,3 and fl,6-glucans (Nebreda et al. 1986; Vazquez de Aldana et al. 1991) . EXG2 codes for a minor exo-fl-glucanase homologous to Exglp (Nebreda et al. 1986; San Segundo et al. 1993) . The BGL2 gene product is an endo-fl,3-glucanase specific for internal fil,3-linkages (Klebl and Tanner 1989; Mrsa et al. 1993) . SPR1/SSG1 encodes a sporulation-specific exo-flglucanase sharing extensive sequence homology with EXG1 (Muthukumar et al. 1993; San Segundo et al. 1993) . Possibly because of the redundant nature of these and other yeast glucanases, deletion analyses of glucanase genes have failed to give rise to obvious cell wall defects. Therefore, the physiological roles of glucanases in cell wall fi-glucan metabolism remain unclear.
To search for new genes involved in cell wall assembly, Ram et al. (1994) carried out a genetic screen for mutants hypersensitive to calcofluor white, a drug which interferes with the extracellular assembly of the cell wall components. A total of 53 calcofluor white hypersensitive complementation groups were isolated, which included both low-mannan and low-glucan mutants. Results from secondary screenings revealed that three of the low-glucan mutants (cwh41-1, cwh47-1 and cwh48-1) were also more resistant to K1 killer toxin than the wild-type strain, suggesting that these mutants had defects in the synthesis of fl,6-glucan. Indeed, genetic complementation analysis revealed that cwh48-1 was allelic to KRE6, which encodes a putative ill,6-gtucan synthase component (Ram et al. 1994; Roemer and Bussey 1991) . Since cwh41-1 and cwh47-1 were not complemented by any of the known kre mutants, they represent new genes possibly involved in cell wall fll,6-glucan assembly. In this study, we report the cloning of the CWH47 gene and the characterization of its functional role in glucan metabolism. In addition, we report the isolation of genes that, when overproduced, lead to a dominant killer-resistant phenotype.
Materials and methods

Yeast and bacterial strains and growth media
The Saccharomyces cerevisiae strains used are listed in Table 1 . Growth conditions and media for yeast were as described (Bussey et al. 1982) . Standard procedures were used for genetic crosses, sporulation of diploids and dissection of tetrads (Sherman et al. 1982) . Yeast transformations were made by the lithium acetate method of Ito et al. (1983) . Killer survival assays for killer toxin sensitivity were performed as described previously (Hutchins and Bussey 1983) . Escherichia coli strain XL1-Blue was used for the propagation of all plasmids. LB and 2YT media were used for bacterial culture (Sambrook et al. 1989 ).
Plasmids
A pRS316-based yeast genomic DNA library (provided by Dr. C. Boone, Simon Fraser University, BC, Canada) was used to clone the CWH47 gene. The EXG1 and PBS2 genes were isolated from a YEp24-based yeast genomic DNA library. The centromeric vector pRS316 was used to subclone the CWH47 gene, and the 2#-based plasmids YEp351 and YEp24 were used for subcloning and overexpression of EXG1 and PBS2 genes, pBluescript II vectors were used for recombinant DNA constructions. Plasmid 2#-EXG1 contains the EXG1 gene on a 3.6 kb HindIII fragment inserted in the HindIII site of YEp351. Plasmid 2#-PBS2 contains the PBS2 gene on a 2.9 kb SpeI-SacI fragment cloned into the XbaI-SacI sites of YEp351.
Selection for killer resistance-inducing genes
The selection was performed by using a 2# plasmid-based yeast genomic DNA library, as genes cloned in a 2# plasmid are maintained at high copy number, and this can often lead to elevated levels of the gene product (Rine 1991; Rine et al. 1983) . After transforming the wild-type strain SE Y62! 0 with a YEp24-based library, a total of 30000 transformants were washed from Petri dishes, and collected into 6 independent pools. About 107 cells from each pool were treated with killer toxin, plated out and incubated at 18°C for 4 to 7 days . After incubation, growing colonies of different sizes were picked and quantitatively checked for killer resistance by measuring cell survival after killer toxin treatment for 3 h. Plasmids from the killer resistant transformants were extracted, amplified in E. coli, and re-transformed into SE Y6210. Plasmids that conferred killer resistance on re-transformation were analyzed further by restriction mapping, subcloning and DNA sequencing.
DNA purification and recombinant DNA techniques.
Yeast DNA was isolated by the procedure of Hoffman and Winston (1987) . Plasmid DNA was prepared from E. coli as described by 
Gene disruption
Deletion disruption mutants were constructed by the method of Rothstein (1983) . A 727 bp SnaBI-BamHI fragment was deleted from the PTC1/CWH47 gene and replaced with a 1.2 kb BamHI fragment containing the URA3 gene, thereby deleting 86% of the coding region. After digestion by HindIII, the DNA fragment carrying the ptclA deletion construct was gel-purified and used to transform a wild-type diploid strain (HAB251-15B) by selecting for uracil prototrophy. The same ptclA deletion construct was also used to transform the YPH499 and MAY1 (pbs2A) haploid strains directly to creat the isogenic ptciA single and pbs2A ptclA double mutants. Southern blot analysis (Southern 1975) of genomic DNA from the resulting transformants indicated that disruptions were at the PTC1/CWH47 locus (data not shown). Similarly, the exglA deletion mutant was created by replacing an internal 138 bp EcoRI fragment of the coding region with a 1.8 kb EcoRI fragment containing the HIS3 gene.
RNA analysis
Total RNA was isolated from exponentially growing cells (at an OD6o o of 0.2-0.3) in YNB medium by a glass-bead lysis method (Rose et al. 1990) . After fractionation on a 1% agarose gel in 20 mM MOPS (morpholinepropanesulfonic acid), 5 mM sodium acetate, 1 mM EDTA, 0.66 M formaldehyde, the RNA samples were transferred onto a Nytran filter and hybridized with [~-32p]dCTPlabelled probes (Fourney et al. 1988) . A 1.1 kb XhoI-XbaI DNA fragment containing the EXG1 coding region was used to detect the EXG1 transcript, and a 0.6 kb BgIII-XhoI DNA fragment from the L29 ribosomal protein gene (provided by Dr. P. Belhumeur, Universit6 de Montr6al, PQ, Canada) was used as an internal control for the amount of mRNA loaded in each lane (Kaufer et al. 1983) . Autoradiograms were scanned with a LKB Ultrascan XL Laser Densitometer.
Cell extract preparation and exo-/3-glucanase assay Cell extracts were prepared from cultures in exponential growth phase (OD600 ~ 0.4), and used to determine the cell-associated exo-//-glucanase activity as described by Santos et al. (1979) . Briefly, samples were incubated with p-nitrophenyl-/3-D-glucoside (p-NPG, 0.25% final concentration) in 1 ml of 50 mM sodium acetate buffer (pH5.2) at 37°C for 1 h and the reaction stopped by putting the tubes in boiling water for 3 min. After removing the protein precipitates by centrifugation, the concentration of released p-nitrophenol was measured by adding 0.9 ml of 4% Na2CO 3 to 0.1 ml of the supernatant and reading the optical density at 415 nm. Protein concentration was determined using the BioRad Protein Assay with bovine serum albumin as a standard.
Analyses of cell wall glucans and intraceltular glycerol
Alkali-insoluble glucans were isolated from stationary-phase yeast cells or isolated cell walls. After /~l,3-glucanase (zymolyase; ICN Pharmaceuticals, Irvine, Calif.) digestion and dialysis, the /31,6-glucan was collected and quantified as described by Boone et al. (1990) . Total glucan (]71,3-plus/31,6-glucan) was determined as the hexose content before dialysis (Roemer and Bussey 1991) , and the /31,3-glucan level was calculated by substracting the /3t,6-glucan content from the total glucan level. To determine the intracellular glycerol level, cells in log phase (OD6o o ~ 0.4) were collected and the glycerol levels were measured enzymatically as previously described (Blomberg and Adler 1989; Blomberg et al. 1988) .
Results
Isolation of EXG1 and PBS2 as killer resistance-inducing genes
To identify additional genes involved in the regulation and synthesis of cell wall glucan, we carried out a selection for genes that, when overproduced, could cause killer resistance in a wild-type strain. The selection was performed by using a 2/~ plasmid-based yeast genomic DNA library, as genes cloned in a 2~ plasmid are maintained at high copy number, and this can often lead to elevated levels of the gene product (Rine 1991; Rine et al. 1983 (Boguslawski and Polazzi 1987; Brewster et al. 1993) . Overproducing EXG1 on a 2/~-based plasmid caused wild-type cells to become resistant to killer toxin with an approximately 40-fold increase in cell survival after toxin treatment. Similarly, a 2/~-PBS2 ptasmid led to an approximately 30-fold increase in survival of killer toxin treated cells (Table 2) .
The exglA and pbs2A mutants were hypersensitive to K1 killer toxin As both EXG1 and PBS2 expressed from 2p-based plasmids in a sensitive wild-type strain resulted in killer resistance, we examined the exglA and pbs2A mutants to see if loss of function of the genes could also cause alterations in killer sensitivity. As shown in Table 2 , both mutants were more sensitive to the toxin than the isogenic wild-type strain. Disruption of the EXG1 gene caused an approximately 2-fold reduction in cell survival after killer toxin treatment, while the pbs2A mutant displayed a cell survival approximately 20 times lower than the wildtype level. Thus, disruption and overexpression of EXG1, or PBS2, had opposing effects on killer toxin sensitivity. Cloning of the CWH47 gene
The cwh47-1 mutant was isolated as a calcofluor whitehypersensitive mutant. Initial studies indicated that the cwh47-1 allele displayed a higher cell wall mannose:glucose ratio (1.39 + 0.02: 1.00) than the wild-type strain (0.94 _+ 0.04: 1.00) and was resistant to K1 killer toxin; suggesting that the mutant had defects in fi-glucan assembly (Ram et al. 1994) . To further characterize the gene identified by the mutant, we cloned the CWH47 gene by functional complementation of the calcofluor white-hypersensitive phenotype of cwh47-1. Five overlapping genomic fragments complementing the cwh47-1 mutation were isolated from a yeast genomic DNA library. Restriction mapping and subcloning analyses localized the complementing activity to a 2.6 kb HindIII fragment. Nucleotide sequences derived from this DNA fragment were identical to the sequence of PTC1, a homolog of the mammalian protein serine/threonine phosphatase 2C (Maeda et al. 1993) , and the restriction map of this 2.6 kb HindIII fragment also matched that of PTC1. We genetically mapped the cwh47-1 locus to the same region as ptcl, which is tightly linked to trpl near the centromere of Chromosome IV (18 out of 18 tetrads were parental ditype for cwh47-1 and trpl segregation). In addition, the ptclA null mutant resembled the cwh47-1 allele in displaying a calcofluor white hypersensitive phenotype (data not shown). To determine directly if cwh47-1 was allelic to ptcl, we crossed the ptclA : : URA3 mutant with the original cwh47-1 allele and analyzed meiotic tetrads from the resulting diploid strain. Of the 10 tetrads tested, all 4 spores from each tetrad were calcofluor white-hypersensitive, with the URA3 marker segregating 2 : 2. In addition, the diploid strain displayed hypersensitivity to calcofluor white. These results demonstrate that the ptclA mutation is tightly linked to the cwh47-1 locus, and fails to complement the calcofluor white hypersensitive phenotype caused by the cwh47-1 mutation. These data indicate that CWH47 is PTC1, and suggest a functional role for the PTC1 phosphatase in yeast cell wall assembly. We will refer to this gene as PTC1/CWH47 for the remainder of this paper. Pbs2p is a member of the Pbs2p-Hoglp MAP kinase signal transduction cascade involved in osmoregulation, and activation of the Pbs2p-Hoglp cascade by increased extracellular osmolarity results in intracellular glycerol accumulation (Brewster et al. 1993) . We observed that, in standard YEPD mudium, activaton of the Pbs2p-Hoglp cascade by PBS2 overexpression led to an approximately 40% increase in glycerol content (from 8.35 _+ 0.40 to 11.86 _ 0.35 nmole per 107 cells). Thus the intracellular glycerol level can be used as an indicator for the activity of the cascade. To independently check that disruption of the PTC1/CWH47 gene could alter the activity of the Pbs2p-Hoglp kinase cascade, we measured the intracellular glycerol levels of various strains grown in standard YEPD medium (Table 3 ). Under this lowosmolarity condition, the pbs2A strain had a similar Effects of EXG1, PBS2 and PTC1/CWH47 genes on cell wall/Lglucan assembly K1 killer toxin uses/~l,6-glucan as a component of its cell wall receptor, and changes in killer sensitivity often reflect alterations in the structure and/or level of cell wall/?l,6-glucan (Bussey 1991) . To determine if changes in Exglp, Pbs2p or Ptclp/Cwh47p activities also caused alterations in cell wall glucans, we examined the levels of /?l,6-glucan and /?l,3-glucan isolated from these various strains (Fig. 1) . Consistent with the killer resistant phenotype, EXG1 overproduction, PBS2 overexpression and PTC1/CWH47 disruption all led to modest but reproducible reductions in cell wall/~l,6-glucan levels. In contrast, the exglA and pbs2A mutants displayed slight increases in the/~l,6-glucan level. The levels of cell wall/~l,3-glucan were unaffected by these manipulations, with the exception of a small elevation of the/?l,3-glucan level in the pbs2A mutant.
PBS2 overexpression and PTC1/CWH47 disruption both lead to EXG1 activation The fact that overproducing PBS2 or deleting PTC1/CWH47 resulted in/~l,6-glucan reductions indicated that the Pbs2p-Hoglp MAP kinase cascade played a functional role in cell surface assembly, most likely through the regulation of genes directly involved in cell wall /~l,6-glucan assembly. The EXG1 gene might be a downstream gene activated by the Pbs2p-Hoglp pathway, because EXG1 and PBS2 were both identified in the same screen, and because overproduction of the PBS2 gene or disruption of the PTC1/CWH47 gene resulted in phenotypes very similar to those seen on EXG1 overexpression. To explore this possibility, we tested if 2#-PBS2 ptasmids or a ptclA mutation could lead to EXG1 activation by examining the EXG1 mRNA levels and the exo-/~-glucanase activities. While both pbs2A and hoglA null mutants contained less EXG1 transcript than the wild-type strain (Fig. 2, compare lane 1 with  lanes 2 and 3) , we observed elevated levels of the EXG1 m R N A in wild-type strains harboring the 2/~-PBS2 plasmid (Fig. 2, compare lanes 1 and 4, 6 and 7) , as well 
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background background as in the ptclA mutant (Fig. 2, compare lanes 6 and 8) . But, PBS2 overproduction in the hoglA mutant strain did not increase the EXG1 mRNA level (Fig. 2 , compare lanes 3 and 5), indicating that the observed EXG1 activation was dependent on an intact Pbs2p-Hoglp kinase cascade. In parallel with the alterations in EXG1 mRNA levels, pbs2A and hoglA displayed lower levels of exo-/~-glucanase activity than the wild type cells (Fig. 3, compare lanes 1-3) ; and PBS2 overexpression or PTC1/CWH47 disruption resulted in increased levels of exo-/?-glucanase activity (Fig. 3, compare lanes  1 and 4, 6-8) . Together, these results indicate that the Pbs2p-Hoglp MAP kinase cascade plays a role in EXG1 regulation. As another test for genetic epistasis between pbs2A and ptclA mutations, we examined the exo-/~-glucanase activities in isogenic pbs2A, ptclA and pbs2A ptclA strains (Table 3) . While the ptclA single mutant showed an approximately 2-fold increase in exo-#-glucanase activity, the pbs2A ptclA double mutant displayed an approximately 15% reduction in exo-/~-glucanase activity similar to the activity observed in the pbs2A single mutant. These results provided further evidence indicating that the loss of function of the Pbs2p kinase is epistatic to the loss of function of the Ptclp/Cwh47p phosphatase.
A null mutation in EXG1 partially alleviates the killer-resistant phenotype caused by PBS2 overexpression and PTC1/CWH47 disruption To further test if Exglp was a downstream target regulated by both Pbs2p and Ptclp/Cwh47p, we examined the effect of EXG1 disruption on the killer-resistant phenotype caused by ptclA null mutation and 2#-PBS2 plasmids. As shown in Table 2 , killer toxin survival of the exglA ptclA double mutant was lower than that of the ptclA single mutant, though still significantly higher than the wild-type strain. Similarly, the exglA strain harboring 2#-PBS2 plasmids also became less resistant to killer toxin than the 2/~-PBS2 containing wild type Fig. 2A , B EXG1 transcript levels. A Northern blot analysis of EXG1 mRNA. Total RNA samples isolated from exponentially growing cultures were analyzed by Northern blotting as described in Materials and methods. The blot was hybridized with 32p-labelled probes specific for EXG1 mRNA (upper panel) and the L29 ribosomal protein transcript (lower panel), which serves as a control for sample loading. The EXG1 transcript of the hoglA mutant displayed a slightly higher mobility than that in the other strains. This is probably a gel running artifact, because the L29 transcript in this lane showed a similarly higher mobility. B Histogram of the EXG1 transcript levels. The relative EXG1 transcript levels were quantified by densitometric scanning of the autoradiograms and expressed as the ratios of Cell extracts prepared from exponentially growing cultures were used to measure the exo-/~-glucanase activities as described in Materials and methods. As controls for the exo-/~-glucanase assay, exo-/~-glucanase activities in the EXG1 disruption mutants and an EXG1 overproducing strain were measured (lanes 9-11). The data shown represent the average results of at least three independent experiments. The error bars represent standard deviations
strain. These results demonstrate that the loss of function of EXG1 partially suppresses the killer resistant phenotype caused by PTC1/CWH47 disruption and PBS2 overexpression, and suggest that EXG1 is a downstream target of Ptclp/Cwh47p and Pbs2p. However, other targets must also contribute to the observed killer resistant phenotypes caused by ptclA and 2kt-PBS2 plasmids, since these strains still retained considerable resistance to killer toxin in the absence of the EXG1 gene.
Discussion
In this study we searched for additional genes involved in yeast cell wall fll,6-glucan assembly. The EXG1 and PBS2 were isolated as genes that, when overexpressed from a 2#-based plasmid, resulted in killer resistance.
The PTCI/CWH47 gene was cloned by functional complementation of a novel killer-resistant mutant cwh47-1 isolated from a screen for calcofluor white hypersensitive mutants (Ram et al. 1994) .
EXG1 codes for an abundant exo-/?-glucanase produced during vegetative growth, and has long been expected to have a function in cell wall/~-gtucan assembly (Nebreda et al. 1986) . In this study, we showed that overexpressing the EXG1 from a 2# plasmid resulted in killer resistance and a modest reduction in cell wall /~l,6-glucan. In constrast, disruption of the EXG1 gene caused the mutant to become more sensitive to killer toxin, and led to a small increase in the /?l,6-glucan level. These results demonstrate that changes in the Exglp activity can lead to alterations in cell wall/~l,6-glucan levels, thus providing experimental support for the expectation that the Exglp exo-/~-glucanase plays a functional role in cell wall glucan metabolism. Although Exglp is active in vitro on both laminarin and pustulan (linear /~l,3-glucan and pl,6-glucan model substrates, respectively) (Nebreda et al. 1986 ), we found that overproducing or deleting the EXG1 gene led to detectable in vivo alterations only in the/~l,6-glucan level. We suggest two possible explanations for this observation that are not mutually exclusive. Exglp is an exo-/%glucanase, and since exo-/~-glucanases hydrolyze glucan polymers from the non-reducing end, Exgl p would preferentially break down the smaller and highly branched fll,6-glucan over the long linear fll,3-glucan. Alternatively, one could hypothesize that Exglp functions specifically as a/?l,6-glucanase on the in vivo cell wall glucans.
PBS2 is a component of the Pbs2p-Hoglp MAP kinase cascade involved in osmoregulation (Brewster et al. 1993) , and PTC1 encodes a protein phosphatase and was isolated as a synthetic lethal mutation in association with a lesion in the protein tyrosine phosphatase gene PTP2 (Maeda et al. 1993) . Both PBS2 and PTC1 are regulatory genes not previously implicated in cell wall assembly. In this study, we provide experimental evidence indicating that the Pbs2p kinase and Ptclp phosphatase are both involved in the regulation of cell wall/?l,6-glucan assembly.
We showed that the Pbs2p kinase and Ptclp/ Cwh47p phosphatase play opposing roles in maintaining killer toxin sensitivity and/~l,6-glucan levels. Either PBS2 overexpression or PTC1/CWH47 disruption result in killer resistance and /?l,6-glucan reductions, while disruption of the PBS2 gene led to a killerhypersensitive phenotype and a slight increase in the pi,6-glucan level. Although the reductions in /~l,6-glucan level caused by PBS2 overexpression or PTC1/CWHe17 disruption were small (approximately 15% or 25% reductions, respectively), they could very likely be the basis for the observed killer-resistant phenotypes for two reasons. Firstly, it has been well documented that a modest reduction in the/?l,6-glucan level (e.g. an approximately 50% reduction in kre6A, or in krellA) can result in a very strong killer-resistant phenotype Roemer and Bussey 1991) ; secondly; a comparable /~l,6-glucan reduction (approximately 27%) caused by EXG1 overexpression results in a similar killer-resistant phenotype. Unlike killer resistance, the killer-hypersensitive phenotype is not well characterized. Although slight increases in both/~l,6-glucan and/?l,3-glucan levels were detected in the pbs2A mutant, the molecular basis for killer hypersensitivity is still not clear. However, since reduced levels and/or altered structures of/~l,6-glucan can lead to killer resistance, one can also imagine that some changes in cell wall structure that retain a functional toxin receptor may lead to increased killer sensitivity.
Genetic epistasis analysis is a powerful tool to study interactions between genes within a regulatory hierarchy, even without a detailed knowledge of the gene products (Avery and Wasserman 1992) . To analyze possible interactions between PBS2 and PTC1/ CWH47, we examined genetic epistasis by comparing the phenotypes displayed by the single mutants and the double mutant. We found that the pbs2AptclA double mutant displayed the same phenotypes as the pbs2A single mutant: while the ptclA single mutant showed killer resistance and elevated Exglp glucanase activity, both the pbs2AptclA double mutant and the pbs2A single mutant displayed hypersensitivity to killer toxin and reduced levels of Exglp glucanase activity. These results demonstrate that the pbs2A mutation is epistatic to the ptclA mutation. In addition, we showed that disruption of PTC1/CWH47 resulted in activation of the Pbs2p-Hoglp cascade, as indicated by an increase in the intracellular glycerol level. Together, these results provide genetic evidence suggesting that the Ptc lp phosphatase negatively regulates the Pbs2p-Hoglp MAP kinase cascade. Interestingly, the same relationship between Ptclp and Pbs2p-Hoglp kinase cascade has recently been independently proposed (Maeda et al. 1994) . In their study, these authors reported that the Pbs2p-Hoglp MAP kinase cascade was regulated by a Slnlp-Ssklp two-component system, and that disruption of SLN1 resulted in constitutive activation of the MAP kinase cascade and lethality. Based on the observations that overexpression of the PTCI gene, as well as the disruption of PBS2 or HOG1 could all suppress the lethal phenotype caused by a slnlA null mutation, they proposed that Ptclp may inactivate the Pbs2p-Hoglp MAP kinase cascade by dephosphorylating Pbs2p and/or Hoglp.
Recently, another yeast MAP kinase cascade, the Pkclp-Mpklp/Stt2p cascade, has been implicated in the regulation of the Bgl2p glucanase activity. Shimizu et al. (1994) reported the characterization of hpo2, which was a novel allele of the PKC1 gene. They observed a 2-to 3-fold increase in the level of the Bgl2p endo-/~-glucanase in the hpo2/pkct mutant, and demonstrated that disruption of the BGL2 gene partially alleviated the hypo-osmolarity-sensitive growth defect of the hpo2 mutant. Based on these phenotypes, Shimizu et al. (1994) suggested that the Pkclp kinase cascade negatively regulates the production of the Bgl2p endo-/%glucanase. In this study, we provide evidence suggesting that the Pbs2p-Hoglp MAP kinase cascade plays a role in Exglp glucanase regulation. We show that disruption of the PBS2 or HOG1 gene slightly decreased the EXG1 mRNA level and exo-/~-glucanase activity, while PBS2 overproduction or PTC1/CWH47 disruption caused an approximately 2-fold activation in EXG1 transcription and a 2 to 3-fold increase in exo-fl-glucanase activity. In addition, we demonstrate that disruption of the EXG1 gene partially suppressed the killer resistant phenotype caused by PBS2 overproduction or PTC1 disruption, indicating the observed cell wall defects could be attributed partially to the elevated Exglp exo-/?-glucanase activity. The fact that the exglA mutation did not completely suppress the killer-resistant phenotype strongly suggests that the Pbs2p-Hoglp MAP kinase cascade also regulates other genes involved in the cell wall assembly, possibly other glucanases or genes required for glucan biosynthesis.
As a summary of our results, we present a working model relating functions of the Pbs2p-Hoglp pathway, the Ptclp/Cwh47p phosphatase and the Exglp glucanase in cell wall/~l,6-glucan metabolism (Fig. 4) . This model is based largely on analyses of cell wall related phenotypes. Although some of these phenotypes were relatively modest, the alterations in EXG1 gene transcription, exo-/~-glucanase activity, sensitivity to K1 killer toxin, cell wall polymer levels, as well as studies on various genetic interactions, were all consistent with the proposed model. However, we cannot yet formally distinguish if EXG1 expression is directly regulated by a transcription factor component of the Pbs2p-Hoglp MAP kinase cascade, or is controlled indirectly by some other downstream target of the cascade. In addition, we stress that it is very likely that the Pbs2p-Hoglp cascade also regulates other genes involved in cell wall glucan assembly, such as other glucanases or genes required for glucan biosynthesis. Further investigations to identify the putative transcription factor involved in EXG1 regulation, and to search for additional downstream targets of the Pbs2p-Hoglp cascade should provide more insights into the regulation of cell wall assembly.
